Abstract
The cardiotoxicity during immunotherapy administration leads to mortality by more than 42% and heart disease-related mortality among immunotherapy-linked cancers is still considered to be underestimated. In this study, the advanced stage of non-small cell lung cancer (NSCLC) with heart disease-related death was selected in accordance with immunotherapy approval time. NSCLC was searched on the Surveillance, Epidemiology, and End Results (SEER) program. Results show that 538 advanced NSCLC cases, those dominated by men and elderly people aged more than 70 years, had a high percentage of heart disease-related death in both eras. The difference between contemporary groups was fairly nonsignificant (P = > 0.05). The overall survival (OS) of all-cause mortality difference showed improved survival in the immunotherapy group (P = 0.0001). In the study of heart disease-related death survival with adjusted data, the NSCLC patients show significant lower survival in the immunotherapy era compared with the nonimmunotherapy era (P = 0.003; hazard ratio [HR] = 1.31; 95% CI = 1.099-1.57). In the multivariate analysis of NSCLC-related immunotherapy, histology revealed that the non-squamous cell type had an independent risk for lower OS than th...Continue Reading
References
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 26, 2016·Journal for Immunotherapy of Cancer·Bridgette A KanzDouglas B Johnson
Mar 15, 2018·Lancet·Javid J MoslehiDouglas B Johnson
Mar 24, 2018·Science·Antoni Ribas, Jedd D Wolchok
Apr 18, 2018·Therapeutic Advances in Medical Oncology·Chiara LazzariVanesa Gregorc
Nov 18, 2018·The Lancet Oncology·Joe-Elie SalemJavid J Moslehi
Jun 13, 2019·The New England Journal of Medicine·Khashayar EsfahaniWilson H Miller
Jun 15, 2019·Journal of the American College of Cardiology·Katelyn M AtkinsRaymond H Mak
Aug 15, 2019·JAMA Network Open·Graça M DoresSilvia Perez-Vilar
Sep 24, 2019·CA: a Cancer Journal for Clinicians·Mike Fillon
Sep 29, 2019·Journal of the American College of Cardiology·Somedeb BallDeepak L Bhatt
Nov 11, 2019·Journal of Cancer Research and Clinical Oncology·Bing-Yen WangYa-Fu Cheng
Dec 27, 2019·JAMA Oncology·Jianchun DuanJie Wang
Jan 8, 2020·Nature Reviews. Clinical Oncology·Anne C Chiang, Roy S Herbst
Jan 16, 2020·Journal of Geriatric Oncology·Doran KsienskiMary Lesperance
Jan 17, 2020·Cancer·Bora YounIssa J Dahabreh
Jan 17, 2020·CA: a Cancer Journal for Clinicians·Lucy Boyce Kennedy, April K S Salama
Apr 2, 2020·Nature Reviews. Cardiology·Joerg Herrmann
Jul 17, 2020·Frontiers in Oncology·Óscar Lapuente-Santana, Federica Eduati
Apr 13, 2021·Journal of Advanced Research·Mohammed SafiJiwei Liu